Docosahexaenoic acid enhances the toxic effect of imatinib on Bcr-Abl expressing HL-60 cells

被引:24
作者
de Lima, Thais Martins [1 ]
Amarante-Mendes, Gustavo P.
Curi, Rui [1 ]
机构
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
imatinib; chronic myeloid leukemia; docosahexaenoic acid; HL-60; cells; Bcr-Abl;
D O I
10.1016/j.tiv.2007.05.008
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
The effect of docosahexaenoic acid (DHA) on the killing efficacy of imatinib on HL-60 cells expressing the Bcr-Abl protein was investigated. Imatinib is an AN tyrosine kinase inhibitor used in the treatment of patients with chronic myeloid leukemia. The pre-treatment with DHA for 24 It raised the effect of imatinib at 100 mu M concentration only. On the other hand, after 72 h pre-treatment, all concentrations of DHA tested (25, 50 and 100 mu M) enhanced the toxic effect of imatinib. These results indicate that long-term pre-treatment with DHA makes Bcr-Abl HL-60 cells more susceptible to the toxic effect of imatinib. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1678 / 1685
页数:8
相关论文
共 56 条
[1]
The effects of immediate enteral feeding with a formula containing high levels of ω-3 fatty acids in patients after surgery for esophageal cancer [J].
Aiko, S ;
Yoshizumi, Y ;
Tsuwano, S ;
Shimanouchi, M ;
Sugiura, Y ;
Maehara, T .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2005, 29 (03) :141-147
[2]
Buchdunger E, 1996, CANCER RES, V56, P100
[3]
Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139
[4]
Studies in the influence of abnormal position upon the motor impulse. [J].
Burnett, CT .
PSYCHOLOGICAL REVIEW, 1904, 11 (06) :370-394
[5]
BURNS CP, 1989, CANCER RES, V49, P3252
[6]
The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus [J].
Clore, JN ;
Allred, J ;
White, D ;
Li, J ;
Stillman, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (11) :1471-1477
[7]
Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP 57148 [J].
Dan, S ;
Naito, M ;
Tsuruo, T .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (08) :710-715
[8]
Essential fatty acids: Biochemistry, physiology and pathology [J].
UND Life Sciences, Shaker Heights, OH, United States .
Biotechnol. J., 2006, 4 (420-439) :420-439
[9]
Comparative toxicity of fatty acids on a macrophage cell line (J774) [J].
de Lima, Thais Martins ;
Cury-Boaventura, Maria Fernanda ;
Giannocco, Gisele ;
Nunes, Maria Tereza ;
Curi, Rui .
CLINICAL SCIENCE, 2006, 111 (05) :307-317
[10]
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells [J].
Deininger, MWN ;
Goldman, JM ;
Lydon, N ;
Melo, JV .
BLOOD, 1997, 90 (09) :3691-3698